For cancer patients who have been prescribed the bisphosphonate drug Zometa, the battles may have only begun. Not only are these individuals forced to battle prostate cancer or myeloma; now, they've been socked with a new kind of problem related to their new medication.
Recently, a condition known as osteonecrosis of the jaw has been exposed as a potential side effect of using Zometa. And although patients who had been prescribed Zometa understood that they were not to use Zometa if pregnant or suffering from renal difficulties, they were unaware of the jaw bone complication.
The condition of osteonecrosis causes any exposed bone of the jaw to cease to heal. (Exposure can be as minimal as when a Zometa user has dental work performed.) After a period of time, the exposed jaw bone starts to "die", causing great pain and trauma to the patient. This inability of the bone to heal itself usually requires at least a round of antibiotics and, at most, surgery to remove pieces of the "dead" bone. For cancer patients who feel they have suffered enough, this side effect of Zometa usage is almost too much to bear.
The knowledge of Zometa's darker side leads many to question whether the drug is actually defective and should never have been allowed to reach the general public. Certainly, media outlets and advocacy groups and individuals have raised this concern in the pages of newspapers and on various websites.
Quite possibly, not enough studies were conducted on Zometa before its approval by the Food and Drug Administration (FDA). And there are some folks convinced that Novartis, the manufacturer of Zometa, may have simply pushed Zometa through to the marketplace before conducting adequate research on the drug.
As a law firm dedicated to the safety of all consumers, we intend to submit claims on behalf of any Zometa patients who have developed osteonecrosis of the jaw. Our team of expert attorneys will fight against Novartis in an effort to win restitution for affected Zometa patients.
Therefore, if you or someone you know has taken Zometa and been diagnosed with osteonecrosis of the jaw or another unexpected side effect, we'd like to hear from you. We'll work together to ensure that drugs like Zometa are no longer rushed to the market at the expense of people's health just to line pharmaceutical companies' pockets. Contact our Zometa lawyers today. 8/14